The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

Israeli doctors have found a way to save patients with COVID-19 in critical condition

Israeli doctors were the first in the world to test an innovative method of treating patients with COVID-19 using a drug based on cells taken from healthy people. It neutralizes the attack of the patient's own immune system on his inflamed body. This attack, called a cytoctine storm, is often the cause of death in COVID-19. This is the first such trial on patients. 9tv.co.il.

Photo: Shutterstock

On September 30, a fifth of five critically ill patients were discharged after receiving an innovative treatment in the first clinical trial of its kind.

The experimental method of treatment was applied to five critically ill patients, two of whom were in critical condition. The trials took place at the Hadassah Ein Kerem hospital in Jerusalem, whose employees, together with the biotechnology company Analybex Therapeutics, have developed a drug that can even put on their feet those patients who, according to doctors, no longer had a chance to survive.

The drug called Alostra was developed based on the research of Professor Dror Mevrurah. Previously, the drug was successfully tested on ten patients with sepsis.

On the subject: Treatment of coronavirus with blood plasma: in the United States allowed to use an untested method

“Alostra is indicated for the treatment of a wide range of medical conditions in which there is an increased activity of the immune system, which leads to an increase in the secretion of proteins by cells of the immune system, called cytokines, and causes a cytokine storm,” explained Professor Mevurah. "It works by treating cells taken from a healthy donor and induced in the laboratory so that when injected into a patient's body, they contain inflammation or a cytokine storm, which is very harmful to the patient."

Miscellaneous treatment Israel coronavirus Special Projects

Read also on ForumDaily:

Scientists have discovered a protein that neutralizes coronavirus without side effects

172 strange symptoms of COVID-19 survivors

Scientists explain why men die from COVID-19 one and a half times more often than women

'This is real torture': the story of a woman living with symptoms of COVID-19 for six months

COVID-19 vaccine: how to become a volunteer and take part in trials

Cheap and effective: steroids can be a lifesaver in COVID-19

Do you want more important and interesting news about life in the USA and immigration to America? Subscribe to our page in Facebook. Choose the "Display Priority" option and read us first. And don't forget to subscribe to ForumDaily Woman and ForumDaily New York - there you will find a lot of interesting and positive information. 



 
1074 requests in 2,960 seconds.